Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=de677e39-3319-4ace-89a1-feb08d4912c8&Preview=1
Date 7/21/2010
Company Name Tethys Bioscience
Mailing Address 5858 Horton Street Emeryville, CA 94608
Company Description The company has become a pioneer in the discovery, development and value creation of novel biological markers for the clinical diagnostics marketplace: Biomarkers. The company believes there is a large unmet need in both the discovery of potentially important biomarkers and the eventual use of them in routine clinical practice for many significant diseases.
Tethys has built expertise, created significant intellectual property, and is executing its business plan around three key areas: Biomarker Discovery, Clinical Validation and Value Creation. Tethys is focused upon biomarkers that yield significant savings to the health care system and improve the quality of life for patients.
Proceeds Purposes These proceeds will support expanded commercialization of the Tethys PreDx™ Diabetes Risk Score (DRS), a simple-to-use, multimarker blood test that enables accurate identification of patients who have a high risk of developing type 2 diabetes within five years.